Latest updates for Kesimpta

Fresh curated links around Kesimpta are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
  • Novartis says MS pill succeeds in two large studies
  • Large study shows how 2 MS treatments stack up in the real world

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 month ago

Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update

Takeda has unveiled more data from its phase 3 trials of zasocitinib, demonstrating that the once-daily pill was able to clear or almost clear scalp psoriasis in 75% of patients.

Read source
biopharmadive.com /1 week ago

Novartis says MS pill succeeds in two large studies

Notably, Novartis revealed that remibrutinib wasn’t associated with the kind of liver-related side effects other BTK inhibitors like it have encountered.

Read source
multiplesclerosisnewstoday.com /2 weeks ago

Large study shows how 2 MS treatments stack up in the real world

Ocrevus (ocrelizumab) and Kesimpta (ofatumumab) are both highly effective at preventing relapses and disability worsening in people with relapsing-remitting multiple sclerosis (RRM...

Read source
healio.com /3 weeks ago

FDA approves two autoinjector formulations for Stelara biosimilar

The FDA has approved a pair of prefilled autoinjector formulations for the Stelara biosimilar ustekinumab-kfce, according to a press release from the manufacturer.Ustekinumab-kfce...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Kesimpta

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

healio.com

Recent coverage from public sources
Public source

Related searches

Kesimpta News Ocrevus RRMS

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing